AliveCor QT Service vs SENSICARDIAC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AliveCor QT Service

by AliveCor

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

AI Verdict

Tool A, AliveCor QT Service, focuses on assessing cardiac safety by measuring QT and QTc intervals from ECGs, primarily to inform medication prescribing decisions. Tool B, SENSICARDIAC, specializes in detecting and classifying heart murmurs using AI integrated with electronic stethoscopes to aid in diagnosis. While both are AI-powered cardiology tools, they address distinct clinical needs and utilize different diagnostic inputs.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary need is precise, instant measurement of QT and QTc intervals to assess cardiac safety. This tool is ideal for healthcare professionals who need to monitor patients for potential drug-induced QT prolongation or to inform medication prescribing decisions where cardiac rhythm is a critical concern, utilizing data from AliveCor 6-Lead ECG devices.

View AliveCor QT Service →

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your focus is on efficiently screening for and classifying heart murmurs, particularly in a primary care or remote monitoring setting. This AI-powered solution, integrated with electronic stethoscopes, is best suited for physicians aiming to quickly differentiate between pathological and physiological murmurs to guide diagnosis and reduce unnecessary specialist referrals.

View SENSICARDIAC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AliveCor QT Service	SENSICARDIAC
Pricing	Varies by product and service, with subscription options available.	Unknown
Deployment	Mobile app, cloud-based platform, EHR integration.	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC offers a guided auscultation process and real-time analysis, which directly enhances the user experience during a physical exam. Its mobile interface has received positive user feedback, with users scoring usability over 4 out of 5. While AliveCor is easy to use, SENSICARDIAC's direct interactive guidance during the diagnostic procedure gives it a slight edge for its specific function.

Clinical Value

AliveCor QT Service

AliveCor QT Service provides instant, accurate QT and QTc interval measurements, which are critical for assessing cardiac safety and informing medication prescribing decisions to prevent potentially fatal arrhythmias. It has FDA clearance and a high negative predictive value of 99.8% for a critical QTc threshold. SENSICARDIAC also offers significant value in murmur detection, but AliveCor's direct impact on drug safety is a more immediate and life-saving application.

Pricing & Value

Tie

Both AliveCor QT Service and SENSICARDIAC require direct contact with the vendor for pricing details. Neither tool provides publicly available pricing information, making it impossible to conduct a head-to-head comparison on this dimension. Therefore, a definitive winner cannot be determined.

Enterprise Readiness

AliveCor QT Service

AliveCor QT Service explicitly highlights its API availability for integration with a wide range of enterprise platforms, including EHR, SDK, CRM, EDC, and PSP platforms. Both tools are HIPAA compliant and offer BAA, but Tool A's detailed integration capabilities indicate a more robust and clearly defined strategy for seamless large-scale deployments within healthcare systems.

Innovation

Tie

Both tools demonstrate significant innovation in their respective cardiology domains. AliveCor's InstantQT provides rapid, AI-powered QT/QTc measurements from a portable 6-lead ECG, revolutionizing drug safety monitoring and remote care. SENSICARDIAC offers real-time, AI-powered heart murmur detection with guided auscultation, enhancing physical examinations and early diagnosis of structural heart disease. Both leverage AI to address critical clinical challenges in novel and impactful ways.

Support & Docs

AliveCor QT Service

AliveCor, as a more established company with a broader product portfolio, explicitly lists 'Support,' 'FAQs,' and 'User Manuals' on its main website, and its KardiaPro portal facilitates easy documentation and patient management. While SENSICARDIAC also has user manuals available, AliveCor's more extensive ecosystem and clearly articulated support resources suggest a more mature and readily accessible support and documentation framework.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AliveCor QT Service	SENSICARDIAC
Tool Name	AliveCor QT Service	SENSICARDIAC
Company	AliveCor	DIACOUSTIC MEDICAL (PTY)
Primary Function	Provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs.	AI-powered, cloud-based heart murmur detection service that classifies murmurs as pathological or physiological.
Input Data Source	AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L)	Electronic stethoscopes (e.g., 3M Littmannu00ae 3200)
Key AI Function	Utilizes AI and deep neural networks for ECG analysis to measure QT and QTc intervals.	AI-powered heart murmur detection and classification (pathological or physiological).

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and SENSICARDIAC.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do the AliveCor QT Service and SENSICARDIAC integrate into a physician's existing clinical workflow, and what are their primary clinical applications?

The AliveCor QT Service integrates by providing instant QT/QTc measurements from AliveCor 6-Lead ECGs, primarily for assessing cardiac safety and informing medication prescribing decisions, especially for drugs known to prolong the QT interval. SENSICARDIAC integrates with electronic stethoscopes to offer real-time, AI-powered heart murmur detection and classification, aiding physicians in diagnosing murmurs and potentially reducing unnecessary referrals during routine physical exams.

What level of integration with Electronic Health Records (EHRs) can physicians expect from each tool, and how does data flow into patient charts?

AliveCor QT Service offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms, allowing for automated and seamless data flow into patient records. SENSICARDIAC provides detailed cardiac reports as downloadable PDFs, which can then be incorporated into a patient's EHR, though this may imply a more manual upload process.

What is the basis for the accuracy and sensitivity claims of each tool, and how have they been validated?

AliveCor QT Service claims 'instant, accurate QT and QTc interval measurements' utilizing AI and deep neural networks for ECG analysis, with studies showing high negative predictive value for QTc interval thresholds. SENSICARDIAC is an AI-powered service that performs analysis against a large validated database of pathological heart murmurs to classify murmurs as pathological or physiological, with reported accuracy above 95 percent.

For which specific specialties or patient populations would each tool offer the most significant clinical advantage?

AliveCor QT Service is well-suited for Cardiology, Emergency Medicine, and Internal Medicine, particularly for patients at risk of drug-induced QT prolongation, such as those on antipsychotic medications or certain antibiotics. SENSICARDIAC is appropriate for Cardiology, Internal Medicine, and Pediatrics, offering advantages in screening for heart murmurs across various age groups, including for occupational physicals and athletes, and can help reduce specialist referrals.

What is the expected learning curve for physicians and their clinical staff to become proficient with each system?

For AliveCor QT Service, the learning curve involves familiarity with using AliveCor 6-Lead ambulatory ECG devices and navigating the KardiaStation app and KardiaPro portal, with nurses reporting improved clinical workflow due to ease of use. SENSICARDIAC requires integration with electronic stethoscopes and utilizes a guided auscultation process, suggesting a learning curve related to mastering the device and the AI-guided workflow.

What audit-trail features are available to track usage, data access, and ensure data integrity within each platform?

AliveCor's enterprise platform emphasizes stringent data security and compliance practices, including ISO 27001 and SOC 2 Type 2 certifications, and its clinical trial solutions highlight compliance and audit trail capabilities. While SENSICARDIAC is a cloud-based service handling sensitive cardiac data, specific audit-trail features are not explicitly detailed in the provided information, though robust data governance is generally expected for such platforms.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AliveCor QT Service or SENSICARDIAC

Backers

Who funded each tool's parent company.